April 14, 2018 01:58 pm PDT
Original Link: http://feeds.boingboing.net/~r/boingboing/iBag/~3/pwYEJBKlFWU/shared-microbial-destiny.html
Goldman Sachs report: "Is curing patients a sustainable business model?"
In Goldman Sachs's April 10 report, "The Genome Revolution," its analysts ponder the rise of biotech companies who believe they will develop "one-shot" cures for chronic illnesses; in a moment of rare public frankness, the report's authors ask, "Is curing patients a sustainable business model?" (more…)
Original Link: http://feeds.boingboing.net/~r/boingboing/iBag/~3/pwYEJBKlFWU/shared-microbial-destiny.html
Share this article:
Tweet
View Full Article